ZA925263B - Modulation and diagnosis of cytokine dysfunctions - Google Patents

Modulation and diagnosis of cytokine dysfunctions

Info

Publication number
ZA925263B
ZA925263B ZA925263A ZA925263A ZA925263B ZA 925263 B ZA925263 B ZA 925263B ZA 925263 A ZA925263 A ZA 925263A ZA 925263 A ZA925263 A ZA 925263A ZA 925263 B ZA925263 B ZA 925263B
Authority
ZA
South Africa
Prior art keywords
dysfunctions
cytokine
diagnosis
modulation
cytokine dysfunctions
Prior art date
Application number
ZA925263A
Inventor
William Carter
Carter William
Original Assignee
Hem Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Pharma Corp filed Critical Hem Pharma Corp
Publication of ZA925263B publication Critical patent/ZA925263B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
ZA925263A 1991-07-16 1992-07-15 Modulation and diagnosis of cytokine dysfunctions ZA925263B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73022991A 1991-07-16 1991-07-16

Publications (1)

Publication Number Publication Date
ZA925263B true ZA925263B (en) 1993-03-31

Family

ID=24934492

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA925263A ZA925263B (en) 1991-07-16 1992-07-15 Modulation and diagnosis of cytokine dysfunctions

Country Status (11)

Country Link
EP (1) EP0596912A4 (en)
JP (1) JPH07501787A (en)
CN (1) CN1068738A (en)
AU (1) AU2268892A (en)
CA (1) CA2113573A1 (en)
IE (1) IE922145A1 (en)
MX (1) MX9204164A (en)
PT (1) PT100688A (en)
TW (1) TW271398B (en)
WO (1) WO1993001717A1 (en)
ZA (1) ZA925263B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US20100239632A1 (en) 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795744A (en) * 1986-07-17 1989-01-03 Hem Research, Inc. Modulation of AIDS virus-related events by double-stranded RNAS
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles
AU1820588A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function
CA1320446C (en) * 1988-06-20 1993-07-20 William A. Carter Modulation of lymphokine-resistant cellular states by dsrnas

Also Published As

Publication number Publication date
PT100688A (en) 1993-10-29
WO1993001717A1 (en) 1993-02-04
EP0596912A4 (en) 1994-07-27
CA2113573A1 (en) 1993-02-04
TW271398B (en) 1996-03-01
EP0596912A1 (en) 1994-05-18
AU2268892A (en) 1993-02-23
CN1068738A (en) 1993-02-10
JPH07501787A (en) 1995-02-23
IE922145A1 (en) 1993-01-27
MX9204164A (en) 1993-05-01

Similar Documents

Publication Publication Date Title
EP0269302A3 (en) Imaging apparatuses and methods
AU8229991A (en) Testing and treatment of visual dysfunctions
EP0349235A3 (en) Niacin-containing composition and its therapeutic use
ZW4090A1 (en) Composition and use
GB9121289D0 (en) Composition and use
AR243240A1 (en) Human interleukin-3 and muteins thereof
EP0204659A3 (en) Polyepoxydes and their use
DE3660256D1 (en) Camphor-di-thiolene-complexes and their use
GB8911294D0 (en) Composition and use
EP0255801A3 (en) Anilinotriazines and their use
ZA925263B (en) Modulation and diagnosis of cytokine dysfunctions
ZA9110045B (en) Pyrimidinyl-and triazinyl-salicylamides and their use and preparation
GB9103631D0 (en) Composition and use
EP0432353A3 (en) Resistor paste and its use
IL116226A0 (en) Substituted n-phenyl and n-heteroarylalkylcarbamates their preparation and use
GB9002217D0 (en) Back rehabilitation procedure and means
GB9120768D0 (en) Diagnostic and prognastic materials and methods
GB9216776D0 (en) Composition and use
GB9000944D0 (en) Compound and use
GR900300184T1 (en) Preparation and its use
EP0569778A3 (en) Surface-active peroxides and their use
GB8929197D0 (en) Sunbeds and suncanopies
ZA925237B (en) Substituted 1-phenyl-1-benzoylamino-5-aminopentanes their preparation and use
GB8917368D0 (en) Combination filter and mixing head
IE880432L (en) Human interleukin-3 and muteins